- Stage of development
-
EEffectivity tested in in-vivo studies with C.elegans and in-vitro human cells cultures.
- Intellectual property
-
Registered biological material
- Intended collaboration
-
Licensing and/or co-development
- Contact
-
Marc EscamillaVice-presidency for Innovation and Transferm.escamilla@dicv.csic.escomercializacion@csic.es
- Reference
-
CSIC/ME/026
Additional information
#Food technology
#Ingredients / Functional food
#Agriculture, livestock and marine science
#Animal health
New strain of the Blautia genus with potential postbiotic effect
A new strain of the Blautia genus has been detected, isolated and identified, and the laboratory tests have found postbiotic properties related with the protection of cells against oxidation and the good functioning of metabolism.
- Market need
-
Recent innovations and findings in the field of human and animal health and nutrition have set the focus in symbiotic microorganisms as key factors for physical well-being and for the treatment of diseases or malfunctions. The discovery of new postbiotics is an emerging market that allows opening new improvements and possibilities in the biotechnology industries, and therefore requires of a continuous scouting of potential candidates that may help fostering innovative developments and opportunities in the field.
- Proposed solution
-
This new Blautia strain, which has been isolated and identified, shows postbiotic properties related with detoxication, improvement of cell metabolism, and cell protection against oxidative stress, which potentially may improve longevity, as shown by in-vivo laboratory tests with C.elegans model. Moreover, further tests with in-vitro human cells have shown that undesired pro-inflammatory effects for the immunological system are much lower that those caused by other symbiotic bacteria. All these makes this strain a promising candidate as postbiotic, with interesting applications in human and animal nutrition.
- Competitive advantages
-
- Its use as a postbiotic allows guaranteeing a safe use for human and animal feeding, without the need of QPS-EFSA certification (European authority).
- The fact that it pertains to a group of bacteria predominant in humans, mammals and birds may facilitate its validation and reglamentation.
- Bacteria of Blautia genus are known for its renowned beneficial properties, being a source of new generation probiotics/postbiotics.
- Its genus have been completely codified, what facillitates future validation.